Franco E. Di Padova

1.7k total citations
22 papers, 1.3k citations indexed

About

Franco E. Di Padova is a scholar working on Immunology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Franco E. Di Padova has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Franco E. Di Padova's work include Synthesis and biological activity (6 papers), Melanoma and MAPK Pathways (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Franco E. Di Padova is often cited by papers focused on Synthesis and biological activity (6 papers), Melanoma and MAPK Pathways (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Franco E. Di Padova collaborates with scholars based in Switzerland, Netherlands and Germany. Franco E. Di Padova's co-authors include Jean H.M. Feyen, P.R. Elford, U. Trechsel, Hermann Gram, Marije I. Koenders, Wim B. van den Berg, Leo A. B. Joosten, Annemieke M. H. Boots, Birgitte Oppers‐Walgreen and Erik Lubberts and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Franco E. Di Padova

22 papers receiving 1.3k citations

Peers

Franco E. Di Padova
Charles G. Garlisi United States
Richard D. Head United States
Claudia Wahl Germany
R. Kurrle Germany
Tony S. Mondala United States
Ronald P. McCaffrey United States
Willem van Dijk Netherlands
Franco E. Di Padova
Citations per year, relative to Franco E. Di Padova Franco E. Di Padova (= 1×) peers Yasuhiro Natori

Countries citing papers authored by Franco E. Di Padova

Since Specialization
Citations

This map shows the geographic impact of Franco E. Di Padova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco E. Di Padova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco E. Di Padova more than expected).

Fields of papers citing papers by Franco E. Di Padova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco E. Di Padova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco E. Di Padova. The network helps show where Franco E. Di Padova may publish in the future.

Co-authorship network of co-authors of Franco E. Di Padova

This figure shows the co-authorship network connecting the top 25 collaborators of Franco E. Di Padova. A scholar is included among the top collaborators of Franco E. Di Padova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco E. Di Padova. Franco E. Di Padova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolbinger, Frank, Christine Huppertz, Anis K. Mir, & Franco E. Di Padova. (2016). IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System. Current Drug Targets. 17(16). 1882–1893. 43 indexed citations
2.
Quesniaux, Valérie, Bernhard Ryffel, & Franco E. Di Padova. (2012). IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 19 indexed citations
3.
Koenders, Marije I., Renoud J. Marijnissen, Leo A. B. Joosten, et al.. (2011). T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3‐rich synovium lacks response to CTLA‐4ig but is successfully treated by interleukin‐17 neutralization. Arthritis & Rheumatism. 64(6). 1762–1770. 21 indexed citations
4.
Koenders, Marije I., Isabel Devesa, Renoud J. Marijnissen, et al.. (2008). Interleukin‐1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin‐1 receptor antagonist–deficient mice. Arthritis & Rheumatism. 58(11). 3461–3470. 83 indexed citations
5.
Koenders, Marije I., Erik Lubberts, Birgitte Oppers‐Walgreen, et al.. (2005). Blocking of Interleukin-17 during Reactivation of Experimental Arthritis Prevents Joint Inflammation and Bone Erosion by Decreasing RANKL and Interleukin-1. American Journal Of Pathology. 167(1). 141–149. 245 indexed citations
6.
Padova, Franco E. Di, et al.. (2005). Anti-endotoxin antibodies. Intensivmedizin und Notfallmedizin. 42(1). 27–38. 1 indexed citations
7.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2005). Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity. Bioorganic & Medicinal Chemistry Letters. 16(2). 262–266. 63 indexed citations
8.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2004). Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 14(13). 3595–3599. 51 indexed citations
9.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2004). SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity. Bioorganic & Medicinal Chemistry Letters. 14(13). 3601–3605. 26 indexed citations
10.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2004). Novel p38 Inhibitors with Potent Oral Efficacy in Several Models of Rheumatoid Arthritis.. ChemInform. 35(43). 1 indexed citations
11.
Müller‐Loennies, Sven, Lore Brade, C. Roger MacKenzie, Franco E. Di Padova, & Helmut Brade. (2003). Identification of a Cross-reactive Epitope Widely Present in Lipopolysaccharide from Enterobacteria and Recognized by the Cross-protective Monoclonal Antibody WN1 222-5. Journal of Biological Chemistry. 278(28). 25618–25627. 38 indexed citations
12.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2002). SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(16). 2109–2112. 48 indexed citations
13.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2000). SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(11). 1261–1264. 41 indexed citations
14.
Padova, Franco E. Di, et al.. (1997). Crossreactive anti LPS monoclonal antibodies: Binding specificity and biological properties. Shock. 7(Supplement). 5–5. 2 indexed citations
15.
Bahrami, Soheyl, et al.. (1997). Monoclonal antibody to endotoxin attenuates hemorrhage-induced lung injury and mortality in rats. Critical Care Medicine. 25(6). 1030–1036. 27 indexed citations
16.
Fehr, Thomas, Martin F. Bachmann, Etienne Bucher, et al.. (1997). Role of Repetitive Antigen Patterns for Induction of Antibodies Against Antibodies. The Journal of Experimental Medicine. 185(10). 1785–1792. 110 indexed citations
17.
Padova, Franco E. Di. (1994). Pharmacology of CsA and FK-506. Perspectives in Drug Discovery and Design. 2(1). 49–56. 5 indexed citations
18.
Padova, Franco E. Di, Helmut Brade, G R Barclay, et al.. (1993). A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infection and Immunity. 61(9). 3863–3872. 155 indexed citations
19.
Padova, Franco E. Di. (1989). Pharmacology of cyclosporine (sandimmune). V. Pharmacological effects on immune function: in vitro studies.. Pharmacological Reviews. 41(3). 373–405. 67 indexed citations
20.
Feyen, Jean H.M., Franco E. Di Padova, U. Trechsel, & P.R. Elford. (1989). Interleukin-6 is produced by bone and modulated by parathyroid hormone. Journal of Bone and Mineral Research. 4(4). 633–638. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026